Cargando…

Hypertension /

The investigation and treatment of hypertension, a leading risk factor for cardiovascular disease throughout the world, remains a challenge, even in developed countries. Although antihypertensives have been available for 50 years, the rational and effective use of the myriad of existing drugs remain...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Cheriyan, Joseph
Otros Autores: McEniery, Carmel, Wilkinson, Ian (Ian Boden)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press, 2010.
Colección:Oxford specialist handbooks.
Oxford medical publications.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn801404353
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 120723s2010 enkaf ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d E7B  |d YDXCP  |d OCLCQ  |d OCLCF  |d NLGGC  |d EBLCP  |d IDEBK  |d OCLCQ  |d D6H  |d STBDS  |d AGLDB  |d OCLCO  |d OCLCQ  |d OCLCA  |d STF  |d OCLCO  |d VNS  |d VTS  |d OCLCA  |d REC  |d TOF  |d OCLCQ  |d M8D  |d OCLCO  |d OCLCQ  |d LIP  |d OCLCQ  |d OCLCA  |d OCLCQ  |d UKAHL  |d AJS  |d OCLCQ  |d OCLCO  |d OCLCQ 
019 |a 801363666  |a 978528672  |a 978909125  |a 1048343340  |a 1119019606  |a 1120891500  |a 1157924277  |a 1158939974  |a 1161180526  |a 1178721487  |a 1184509492  |a 1190683052  |a 1241809665  |a 1249469449 
020 |a 9780191575211  |q (electronic bk.) 
020 |a 0191575216  |q (electronic bk.) 
020 |a 0191726044 
020 |a 9780191726040 
020 |a 128357974X 
020 |a 9781283579742 
020 |a 9786613892195 
020 |a 661389219X 
020 |z 9780199229550 
020 |z 0199229554 
029 1 |a AU@  |b 000062594144 
029 1 |a DEBBG  |b BV043157871 
029 1 |a DEBSZ  |b 421395478 
035 |a (OCoLC)801404353  |z (OCoLC)801363666  |z (OCoLC)978528672  |z (OCoLC)978909125  |z (OCoLC)1048343340  |z (OCoLC)1119019606  |z (OCoLC)1120891500  |z (OCoLC)1157924277  |z (OCoLC)1158939974  |z (OCoLC)1161180526  |z (OCoLC)1178721487  |z (OCoLC)1184509492  |z (OCoLC)1190683052  |z (OCoLC)1241809665  |z (OCoLC)1249469449 
050 4 |a RC685.H8  |b C44 2010eb 
060 4 |a 2010 F-360 
060 4 |a WG 39 
072 7 |a MED  |x 010000  |2 bisacsh 
082 0 4 |a 616.132  |2 22 
049 |a UAMI 
100 1 |a Cheriyan, Joseph. 
245 1 0 |a Hypertension /  |c Joseph Cheriyan, Carmel M. McEniery, Ian B. Wilkinson. 
260 |a Oxford ;  |a New York :  |b Oxford University Press,  |c 2010. 
300 |a 1 online resource (xxii, 313 pages, 9 unnumbered pages of plates) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Oxford specialist handbooks 
490 1 |a Oxford medical publications 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Symbols and abbreviations; 1 Aetiology and pathophysiology; Haemodynamics; Haemodynamics in hypertension; Central versus peripheral blood pressure; Physiology and pathophysiology of blood pressure regulation; Role of the autonomic nervous system; Role of the kidneys; Interplay between autonomic and renal mechanisms; Vascular structure and function in essential hypertension; Large arteries; Genetics of essential hypertension; Environmental influences on blood pressure; Physical activity; Diet; Salt intake; Potassium intake; Alcohol; Stress; Obesity. 
505 8 |a Experimental models of hypertension2 Essential hypertension; Background; Prevalence and incidence; Isolated systolic hypertension; Systolic /diastolic hypertension; Isolated diastolic hypertension; Assessment; History; Examination; Blood pressure measurement; Assessing end-organ damage; Investigations in hypertension; Biochemistry; Basic biochemistry; Renin and aldosterone; Dipstick urinalysis; Physiological measurements; Electrocardiography; Home blood pressure; 24-hour ambulatory blood pressure monitoring; Echocardiography; Management; Prognosis and risk stratification. 
505 8 |a Non-pharmacological managementNon-pharmacological management: background; Salt; Dietary intervention, weight loss, and exercise; Alcohol; Other methods; Pharmacological management; Pharmacological management: background; Compliance; Stepped care versus combination therapy; Targets and evidence basis; Treatment algorithms; Resistant hypertension; Hypertensive emergencies; 3 Specific investigations for secondary hypertension; Introduction; Phaeochromocytoma; Urine catecholamines and metanephrines; Plasma catecholamines and metanephrines; Dynamic testing; Clonidine suppression test. 
505 8 |a Pentolinium suppression testConn's syndrome; Fludrocortisone suppression test; Saline suppression test; Imaging; Computed tomography; Magnetic resonance imaging; Nuclear medicine: adrenal; Nuclear medicine: kidney; Interventional radiology; 4 Secondary hypertension; Vascular; Co-arctation of the aorta; Renal artery stenosis; Endocrine; Hyperaldosteronism; Conn's syndrome; Bilateral adrenal hyperplasia; Cushing's syndrome; Phaeochromocytoma; Hyperparathyroidism; Hyperthyroidism; Renal; Renal parenchymal disease; Adult polycystic kidney disease; Renal tumours; Drugs; Liquorice; Alcohol. 
505 8 |a Oral contraceptive pillSteroids; Non-steroidal anti-inflammatory drugs; Immunosuppressives; Vascular endothelial growth factor inhibitors; Monoamine oxidase inhibitors; Cocaine; Heavy metals; 5 Monogenic syndromes; Introduction; Pathophysiology; Apparent mineralocorticoid excess; Mineralocorticoid receptor-activating mutation; Gordon's syndrome; Hypertensive congenital adrenal hyperplasia; Glucocorticoid remediable aldosteronism; Liddle's syndrome; Bartter's syndrome; Gitelman's syndrome; 6 Special populations; Pregnancy; Pregnancy: chronic hypertension; Pregnancy: gestational hypertension. 
520 |a The investigation and treatment of hypertension, a leading risk factor for cardiovascular disease throughout the world, remains a challenge, even in developed countries. Although antihypertensives have been available for 50 years, the rational and effective use of the myriad of existing drugs remains a concern, as does the desire to identify patients with secondary hypertension from the mass of individuals with primary or essential hypertension. The aim of this handbook is to provide state-of-the-art information concerning the pathophysiology, diagnosis, investigation and management of hyperte. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Hypertension. 
650 1 2 |a Hypertension 
650 6 |a Hypertension artérielle. 
650 7 |a MEDICAL  |x Cardiology.  |2 bisacsh 
650 7 |a Hypertension.  |2 fast  |0 (OCoLC)fst00965831 
700 1 |a McEniery, Carmel. 
700 1 |a Wilkinson, Ian  |q (Ian Boden) 
776 0 8 |i Print version:  |a Cheriyan, Joseph.  |t Hypertension.  |d Oxford ; New York : Oxford University Press, 2010  |z 9780199229550  |w (DLC) 2010278287  |w (OCoLC)423583044 
830 0 |a Oxford specialist handbooks. 
830 0 |a Oxford medical publications. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467532  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH37530478 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL975616 
938 |a ebrary  |b EBRY  |n ebr10581370 
938 |a EBSCOhost  |b EBSC  |n 467532 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 389219 
938 |a Oxford University Press USA  |b OUPR  |n EDZ0000039335 
938 |a YBP Library Services  |b YANK  |n 12890007 
938 |a YBP Library Services  |b YANK  |n 9316038 
994 |a 92  |b IZTAP